葡萄糖皮质体受体:异构体,功能和对葡萄糖皮质体敏感性的贡献
Jack Lockett1,2,3, Warrick J Inder2,3, Vicki L Clifton1
1Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4101, Australia.
Endocrine reviews
|March 29, 2024
概括
葡萄糖皮质类药物提供抗炎益处,但会引起副作用. 本综述探讨了葡萄糖皮质体受体 (GR) 结构,异型及其在葡萄糖皮质体敏感性和耐药性中的作用.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物对平衡至关重要,合成形式用于治疗抗炎作用.
- 治疗用途受到剂量和持续时间依赖的副作用的限制,具有显著的个体间变异性.
- 葡萄糖皮质体受体 (GR) 调解这些效应,但对其功能的传统理解正在演变.
研究的目的:
- 审查葡萄糖皮质体受体 (GR) 的结构和功能.
- 讨论GR异型的性质及其影响.
- 探索GR对健康和疾病中的葡萄皮质激素敏感性和耐药性的贡献.
主要方法:
- 关于葡萄糖皮质体受体 (GR) 功能现有研究的文献综述.
- 对研究GR异型及其影响的研究进行分析.
- 综合有关葡萄糖皮质激素敏感性和耐药性机制的数据.
主要成果:
- 葡萄糖皮质类药物的效果是类的,影响所有组织.
- 正在重新评估GR功能的传统模型 (对抗炎症的转抑制,对代谢效应的转活化).
- 发现多个GR异型的发现挑战了正统的理解.
结论:
- 包括异构体在内的GR功能的复杂性会影响对葡萄糖皮质类药物的可变反应.
- 了解GR异构体对于破译葡萄糖皮质体敏感性和耐药性至关重要.
- 对GR结构-功能关系的进一步研究可以为治疗策略提供信息.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Intracellular Hormone Receptors
55.2K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
55.2K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K


